Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Alcohol-Associated Hepatitis | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

The prevalence of alcohol use disorder (AUD) has been steadily increasing over the past
decade. In parallel, alcohol-associated liver disease (ALD) has been increasing at an …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …

Alcohol‐associated liver disease (ALD) is a major driver of global liver related morbidity and
mortality. There are 2.4 billion drinkers (950 million heavy drinkers) and the lifetime …

Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …

Alcohol consumption represents a major factor of morbidity and mortality, with a wide range
of adverse medical implications that practically affect every organ system. It is the fifth major …

Background and Aims Tolerance is transplantation's holy grail, as it denotes allograft health
without immunosuppression and its toxicities. Our aim was to determine, among stable long …

Background & Aims The long-term impact of alcohol-related public health policies (PHPs) on
disease burden is unclear. We aimed to assess the association between alcohol-related …